» Articles » PMID: 10809780

Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 May 16
PMID 10809780
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

Heparan sulfate-regulated transmembrane tyrosine kinase receptor FGFR4 is the major FGFR isotype in mature hepatocytes. Fibroblast growth factor has been implicated in the definition of liver from foregut endoderm where FGFR4 is expressed and stimulation of hepatocyte DNA synthesis in vitro. Here we show that livers of mice lacking FGFR4 exhibited normal morphology and regenerated normally in response to partial hepatectomy. However, the FGFR4 (-/-) mice exhibited depleted gallbladders, an elevated bile acid pool and elevated excretion of bile acids. Cholesterol- and bile acid-controlled liver cholesterol 7alpha-hydroxylase, the limiting enzyme for bile acid synthesis, was elevated, unresponsive to dietary cholesterol, but repressed normally by dietary cholate. Expression pattern and cholate-dependent, cholesterol-induced hepatomegaly in the FGFR4 (-/-) mice suggested that activation of receptor interacting protein 140, a co-repressor of feed-forward activator liver X receptor alpha, may mediate the negative regulation of cholesterol- and bile acid-controlled liver cholesterol 7alpha-hydroxylase transcription by FGFR4 and cholate. The results demonstrate that transmembrane sensors interface with metabolite-controlled transcription networks and suggest that pericellular matrix-controlled liver FGFR4 in particular may ensure adequate cholesterol for cell structures and signal transduction.

Citing Articles

Engineering an fgfr4 knockout zebrafish to study its role in development and disease.

Harrison E, Jay A, Kent M, Sukienik T, LaVigne C, Kendall G PLoS One. 2024; 19(11):e0310100.

PMID: 39576839 PMC: 11584112. DOI: 10.1371/journal.pone.0310100.


Branched-chain amino acids promote hepatic Cyp7a1 expression and bile acid synthesis via suppressing FGF21-ERK pathway.

Wang J, Zhong M, Liu Y, Yu J, Wang Y, Zhang X Acta Pharmacol Sin. 2024; 46(3):662-671.

PMID: 39567750 PMC: 11845675. DOI: 10.1038/s41401-024-01417-2.


Sodium sulphate ameliorates hypercholesterolemia via the upregulation of in hepatocytes and alleviates hepatic insulin resistance via the downregulation of in mice with high cholesterol diets.

Yang Y, Yu S, Rong H, Lei Z, Yang C, Wu H Exp Ther Med. 2024; 28(3):361.

PMID: 39071912 PMC: 11273247. DOI: 10.3892/etm.2024.12650.


Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development.

Li T, Chiang J Pharmacol Rev. 2024; 76(6):1221-1253.

PMID: 38977324 PMC: 11549937. DOI: 10.1124/pharmrev.124.000978.


Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho.

Aaldijk A, Verzijl C, Jonker J, Struik D Front Endocrinol (Lausanne). 2023; 14:1150222.

PMID: 37260446 PMC: 10229096. DOI: 10.3389/fendo.2023.1150222.